After demonstrating that enhanced sFRP2 expression contributes towards OS migratory and invasive potential in vitro, we next investigated the effects of reducing sFRP2 in highly metastatic osteosarcoma cells. The gene discussed is SFRP2; the disease is osteosarcoma.